Halma, the renowned global group of life-saving technology companies, today announced its acquisition of the TeDan group of companies, including TeDan Surgical Innovations, Inc., West Coast Surgical, LLC, Axcess Surgical Innovations, LLC, and TeDan Surgical Innovations GmbH. The initial cash consideration for this acquisition is US$89.1 million (approximately £72 million).

Transaction Details:

Financials: The acquisition, valued at US$89.1 million on a cash- and debt-free basis, will be funded from Halma’s existing facilities. After adjusting for tax benefits, the net initial consideration is approximately US$79.3 million (£64 million).

Additional Payments: An earn-out consideration of up to US$10.9 million (£9 million) is contingent on TeDan’s performance until June 2024.

Company Overview: TeDan, headquartered in Houston, Texas, and Half Moon Bay, California, is a leader in developing and supplying surgical access systems, primarily for spinal surgery, with the majority of its sales in the USA.

TeDan’s Performance:

Financial Health: TeDan’s unaudited revenue for the 12 months ending March 31, 2023, was US$29.2 million (£24 million), with a Return on Sales exceeding Halma’s target range of 18-22%.

Integration into Halma: As a new part of Halma’s Healthcare sector, TeDan will operate as a standalone company under its current management.

Statements from CEOs:

Danny Fishman, CEO of TeDan: Emphasized the global growth in healthcare spending and TeDan’s decade-long leadership in surgical access innovation. He expressed enthusiasm for joining Halma to expand in the U.S. and internationally, aligning with the shared goal of a healthier future.

Marc Ronchetti, Group CEO of Halma: Highlighted how TeDan complements Halma’s Healthcare sector, pointing to the aging population and evolving surgical treatments as drivers for growth. He welcomed the TeDan team to Halma, looking forward to expanding their global impact.

Conclusion:

Halma’s acquisition of TeDan represents a strategic expansion in the healthcare technology sector, tapping into the growing demand for innovative surgical solutions. This move not only strengthens Halma’s portfolio but also positions TeDan for greater global reach and impact in the healthcare industry.

  Danny Fishman, Halma, Marc Ronchetti, TeDan, USA